For those in Roanoke interested in semaglutide weight loss, Wegovy presents an effective, FDA-approved alternative to Ozempic
First, the known mechanism of action and body water loss properties for semaglutide may explain the risk of hyposalivation in patients on semaglutide
It is currently under clinical investigation for the management of obesity and type 2 diabetes (as demonstrated in a phase 2 trial published in the New England Journal of Medicine), and as of the time of writing, it has not received marketing authorisation from the Medicines and Healthcare products Regulatory Agency (MHRA) or the European Medicines Agency (EMA)
While this connection is still being researched, one tiny 2019 study found that people taking GLP-1s, particularly women, reported that the medication changed the kind of foods they preferred
Learn more about the latest options and personalized strategies for weight management and metabolic health by scheduling an appointment with Dr